Drug Shortage Report for PROCYTOX
| Report ID | 225670 |
| Drug Identification Number | 02241800 |
| Brand name | PROCYTOX |
| Common or Proper name | Procytox |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CYCLOPHOSPHAMIDE |
| Strength(s) | 2000MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 2G |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2024-04-19 |
| Actual start date | 2024-04-19 |
| Estimated end date | 2024-05-06 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-26 |
| Company comments | Release expected April 25th, 2024 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-04-26 | French | Compare |
| v4 | 2024-04-26 | English | Compare |
| v3 | 2024-04-20 | English | Compare |
| v2 | 2024-04-19 | French | Compare |
| v1 | 2024-04-19 | English | Compare |
Showing 1 to 5 of 5